Healthcare - Biotechnology - NASDAQ - US
$ 4.33
0 %
$ 37.4 M
Market Cap
-1.01
P/E
CASH FLOW STATEMENT
-31.1 M
OPERATING CASH FLOW
10.7 M
INVESTING CASH FLOW
-576 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Lumos Pharma, Inc.
| Net Income | -34 M |
| Depreciation & Amortization | 44 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 2.32 M |
| Change in Working Capital | 965 K |
| Others | 287 K |
| Free Cash Flow | -31.1 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||||
| Net Income | (34.0) | (31.1) | (30.4) | (5.7) | (43.0) | (53.6) | (72.0) | (85.2) | (40.4) | 102.9 | (31.2) | (23.3) | (18.1) | (16.6) | (9.7) | (9.2) |
| Depreciation & Amortization | 44 K | 49 K | 0.2 | 0.6 | 1.1 | 1.1 | 1.4 | 2.1 | 1.6 | 1.1 | 0.9 | 0.8 | 0.7 | 0.7 | 0.3 | 0.3 |
| Deferred Income Tax | 0 | 0 | 0 | (9.5) | 0 | 0 | 0 | 4.0 | (15.9) | (8.6) | (4.4) | (3.2) | 1 K | 0.3 | (0.7) | 0 |
| Stock Based Compensation | 2.3 | 2.3 | 2.9 | 1.1 | 6.7 | 17.1 | 18.5 | 16.7 | 15.9 | 8.6 | 4.4 | 3.2 | 2.5 | 1.5 | 0.7 | 0.1 |
| Other Operating Activities | (0.4) | 26 K | 14 K | (5.9) | 0.4 | 0.1 | 0.1 | (0.4) | 15.9 | 8.6 | 4.4 | 3.2 | 1 K | 1.0 | 0.7 | 5 K |
| Change in Working Capital | 1.0 | 2.1 | (2.3) | (3.6) | 4.6 | (2.7) | 3.6 | (3.1) | (1.2) | (3.5) | 0.1 | (1.2) | 1.9 | (0.3) | (0.4) | (0.2) |
| Cash From Operations | (31.1) | (26.6) | (29.6) | (23.0) | (30.2) | (37.9) | (48.3) | (65.9) | (24.1) | 109.1 | (25.8) | (20.5) | (12.9) | (13.3) | (9.1) | (8.9) |
| INVESTING CASH FLOW | ||||||||||||||||
| Capital Expenditures | 0 | 21 K | 30 K | 30 K | 2 K | 7 K | 43 K | (2.2) | (4.0) | (1.7) | (1.4) | (1.3) | (0.3) | (2.9) | (1.4) | (0.4) |
| Other Items | 10.7 | (11.3) | 26.0 | 116.7 | 79 K | 0.1 | 0.3 | 2.2 | 10.2 | (12.1) | 1.2 | 1.0 | (0.2) | 0.2 | (0.1) | (2.7) |
| Cash From Investing Activities | 10.7 | (11.4) | 26.0 | 116.6 | 77 K | 0.1 | 0.2 | 66 K | 6.2 | (13.8) | (0.1) | (0.3) | (0.5) | (2.7) | (1.5) | (3.1) |
| FINANCING CASH FLOW | ||||||||||||||||
| Common Stock Repurchased | (1.3) | (0.7) | (0.1) | 0 | 36 K | (0.3) | (0.3) | 82 K | (0.6) | (0.2) | 0 | 4 K | 13 K | (0.5) | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 27 K | 0 | (0.2) | (0.2) | (0.3) | (0.2) | 90 K | (0.2) | 0.2 | (0.2) | 0.9 | 9 K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 K | 1 K | 0 | 0 | 0 |
| Other Financing Activities | 9 K | (0.1) | (0.1) | 0.1 | 58 K | 0.3 | 1.4 | 2.2 | 10.3 | 6.6 | 0.9 | 1.1 | 5.0 | 8.8 | 19.6 | 17.9 |
| Cash From Financing Activities | (0.6) | (0.8) | (0.2) | 75 K | 59 K | (0.1) | 75.3 | 1.9 | 23.1 | 33.9 | 67.0 | 1.5 | 42.4 | 11.3 | 19.6 | 17.9 |
| CHANGE IN CASH | ||||||||||||||||
| Net Change In Cash | (20.9) | (38.8) | (3.9) | 93.7 | (30.2) | (38.0) | 27.2 | (64.1) | 5.2 | 129.1 | 41.0 | (19.2) | 28.9 | (4.6) | 8.9 | 5.9 |
| FREE CASH FLOW | ||||||||||||||||
| Free Cash Flow | (31.1) | (26.6) | (29.7) | (23.0) | (30.2) | (37.9) | (48.3) | (68.2) | (28.1) | 107.4 | (27.2) | (21.8) | (13.2) | (16.2) | (10.5) | (9.3) |